List of received applications (By symposium/topics code)

Top > Application > List of received applications (By symposium/topics code)



7) Biochemical engineering

7-e. Medical

Most recent update: 2025-01-22 22:44:01

The keywords that frequently used
in this topics code.
KeywordsNumber
Therapeutic drug monitoring3*
cell sorting2
Vancomycin2
transdermal delivery2
Cell morphology2
Molecularly Imprinted Polymer2
perfluorocarbon1

ACKN
No.
Title/Author(s)KeywordsStyle
35Lipid Nanoparticle Formation Encapsulating mRNA Using a Microreactor for Mixing at a High Flow Rate Ratio
(Hitachi) *(Reg)Asano Yukako, (Hitachi Plant Services) (Cor)Iwayama Daisuke, (Cor)Oda Masashi, (ARCALIS) Futawatari Hiroki, Kodaka Gento, Ito Susumu
Lipid Nanoparticle
mRNA
Microreactor
O
58In vitro hair reconstruction model for testing hair regeneration activity
(Yokohama Nat. U.) *(Stu)Migita Yuki, Tachibana Ryuji, (Stu)Nanmo Ayaka, (Reg)Kageyama Tatsuto, (Reg)Fukuda Junji
hair follicle
alternative to animal testing
drug testing
P
60Expansion Culture of Human Hair Follicle Stem Cells for Hair Regeneration Medicine
(Yokohama Nat. U.) *(Stu)Takanashi Haruka, (Yokohama Nat. U./KISTEC) Yan Lei, (Reg)Kageyama Tatsuto, (Tokyo Hair Transplant Cosmetic Surgery) Sato Fumihito, (Yokohama Nat. U./KISTEC) (Reg)Fukuda Junji
hair regeneration medicine
hair follicle stem cells
cell expansion culture
P
71Development of ionic liquid formulations for organ-selective transdermal delivery of nucleic acid drugs
(Kyushu U.) *(Stu)Toyofuku Kiyohiro, (Reg)Wakabayashi Rie, (Reg)Kawaguchi Yoshiro, (Reg)Kamiya Noriho, (Reg)Goto Masahiro
nucleic acid drugs
transdermal delivery
organ-selective delivery
O
100Non-invasive quality assessment of fibroblast spheroids by near-infrared imaging and AI analysis
(Nagoya U.) *(Stu)Sakai R., Kawasaki M., (Sumitomo Electric Industries) Igarashi Y., Suganuma H., (Nagoya U.) (Reg)Tanaka K., (Reg)Kato R.
fibroblast spheroid
non-destructive quality assessment
near-infrared imaging
P
117Development of image-based prediction model for macrophage M2 polarization potency of mesenchymal stem cells
(Nagoya U.) *(Stu)Koide K., (Reg)Tanaka K., (Reg)Kato R.
co-culture
mesenchymal stem cell
image analysis
P
150Development of a deformability-based cell sorting method using inclined HDF microfluidic channels
(Chiba U.) *(Stu)Terada Toranosuke, Jung Sanghyeob, Utoh Rie, (Reg)Yamada Masumi
Cell sorting
Deformability
Microfluidics
P
199Colorimetric visualization of the breast cancer metastasis based on the size-dependent transport of fluorescent nanoparticles
(UTokyo) *(Stu)Ono H., (Reg)Nakamura N., (Reg)Ohta S.
conjugated polymer nanoparticles
sentinel lymph node biospy
breast cancer metastasis
P
207Data augmentation technology for morphology-based prediction model of human fibroblasts
(Nagoya U.) *(Stu)Katayama S., Kimura K., (Reg)Tanaka K., (Reg)Kato R.
Data augmentation
Cell morphology
Machine learning
P
273Development of a facile multiplex quantification method for disease-related miRNAs using gold nanoparticle size as label
(UTokyo) *(Stu)Nara Y., (Reg)Nakamura N., (Reg)Ohta S.
gold nanoparticles
size
nucleic acid
P
289Double Synergy between Linear and Cyclic Antimicrobial Peptides
(U. Tokyo IIS) *(Stu)Zhang Jing, (Reg)Sugihara Kaori
Antimicrobial peptides
Synergy
linear and cyclic peptides
O
293Multiplexed quantification of cancer-related miRNAs via multi-color and multi-cycle DNA catalytic reactions
(UTokyo) *(Int)Wang L., (Reg)Nakamura N., (Reg)Ohta S.
DNA catalytic reaction
multiplexed miRNA detection
cancer diagnosis
P
295Development of transdermal vaccine formulation using transdermal penetration enhancer and verification of efficacy
(Kyushu U.) *(Stu)Tanaka Keisuke, (Reg)Kawaguchi Yoshiro, (Reg)Wakabayashi Rie, (Reg)Kamiya Noriho, (Reg)Goto Masahiro
Transdermal administration
Vaccine
Immunology
O
319Study on the effect of perfluorocarbon-based artificial oxygen careers for preservation of rat pancreas
(UTokyo) *(Stu)Endo Aoi, (Reg)Inagaki Natsuko F., (Reg)Ito Taichi
artificial oxygen career
perfluorocarbon
organ preservation
P
358Disposable sensor for detecting vancomycin in human serum using molecularly imprinted carbon paste
(Shibaura Inst. Tech.) *(Reg)Yoshimi Yasuo, (Stu)Hirata Aoi, (Stu)Otsuka Riku, Toyama Shigeru, (Reg)Aaryashree, (Saitama Med. U.) Saito Ken-ichi
Molecular Imprinting
Disposable Sensor
Therapeutic Drug Monitoring
O
420Effective Insulin Delivery via Ionic Liquid-Based Transdermal Patch
(Kyushu U.) *(Stu)Li Yamin, (Reg)Kawaguchi Yoshiro, (Reg)Wakabayashi Rie, (Reg)Kamiya Noriho, (Reg)Goto Masahiro
Transdermal patch
Insulin
Ionic liquid
P
427Application of formulation design based on Supraparticles to drug delivery systems
(Wakayama Med. U.) *(Reg)Kadota Kazunori, Ikeda Mayumi, Fukuta Tatsuya
Supraparticles
drug delivery systems
nanoparticles
O
453Morphology-based quantitative evaluation of cryopreservation effects
(Nagoya U.) *(Stu)Kobayashi K., (Reg)Tanaka K., (Nagoya U./Inst. Nano-Life-Systems) (Reg)Kato R.
Cell morphology
Cryopreservation
Image-based analysis
P
455Influence of direct contact between hepatic stellate cells (HSCs) and hepatocytes on HSC activation
(U. Tokyo) *(Stu)Imahashi Kenta, (Reg)Tokito Fumiya, Gong Ya, Choi Hyunjin, Katsuda Takeshi, (Reg)Nishikawa Masaki, (Reg)Sakai Yasuyuki
Hepatic stellate cells
Liver fibrosis
In vitro liver model
P
479Synthesis and sorting of molecularly imprinted nanoparticles with high specific binding capacity for vancomycin detection
(Shibaura Inst. Tech.) *(Stu)Kusano Shota, (Reg)Yoshimi Yasuo
Nanoparticle
Molecularly Imprinted Polymer
P
485Myotube formation on nonwovens composed of physically ground silk nanofibers
(Osaka U.) *(Stu)Hasegawa Kei, (Reg)Sakai Shinji
Silk Fibroin
Myoblast
Skeletal muscle
P
489Establishment of iPS cells derived from Chinese hamster lung cells to improve antibody production efficiency
(Osaka U.) *(Stu)Tenpaku Rikuto, Fujioka Haruki, Kanai Guirong, (Reg)Yamano-Adachi Noriko, (Reg)Omasa Takeshi
iPS cell
Chinese hamster
Antibody
P
508Optimization of the wiring material in the sensor chip used to measure vancomycin concentration in human serum
(Shibaura Inst. Tech.) *(Stu)Sambongi Shoei, (Stu)Hirata Aoi, (Reg)Aaryashree, (Reg)Yoshimi Yasuo
Vancomycin
Therapeutic drug monitoring
Molecularly Imprinted Polymer
P
511A Novel Stable Nanogel-Emulsion for Enhanced Hydrophobic Drug Delivery via Versatile Administration Routes
(Kyushu U.) *(Stu)Chen Chongzhi, Kawasaki Norifumi, (Stu)Hirota Yuya, Abd El-Emam Mahran, (Reg)Ikegami Yasuhiro, (Reg)Sakai Yusuke, (Reg)Ijima Hiroyuki
Nanogel-Emulsion
Versatile Administration Routes
Drug Delivery System
P
513Effect of a Film-Forming Emulsion on Ultraviolet B-induced Skin Damage
(Kyushu U.) *(Stu)Hu Jia, Zhou Yu, Wu Lichun, (Reg)Ikegami Yasuhiro, (Reg)Sakai Yusuke, (Reg)Ijima Hiroyuki
Transdermal drug delivery system
Ultraviolet B-induced skin damage
Emulsion
O
543Detection of virus-induced cytopathic effects using deep learning
(Nagoya U.) *(Reg)Tanaka K., Shiina T., (Nat. Inst. Health Sciences) Hirai T., Kusakawa S., Kono K., Yasuda S., (Nagoya U.) (Reg)Kato R.
Viral contamination detection
Deep learning
Cell therapy products
O
555Development of single-cell photo-capture technology using photoactivatable PEG lipid
(Osaka U.) *(Reg)Yamahira Shinya, (U. Tokyo) (Stu)Umeda Yuki, (Osaka U.) (Reg)Yamaguchi Satoshi
cell sorting
PEG lipid
circulating tumor cells
P
578Teratogenicity Assessment of hiPSCs Embryoid Body based on FGF Signal Disruption
(Yokohama Nat. U.) *(Stu)Nurul Syakirin Binti Borhan, (Reg)Fukuda Junji
Teratogenicity
Signal pathway
Luminescence
P
605Mechanism of transdermal delivery using different eutectic mixture
(Doshisha U.) *(Reg)Tahara Yoshiro, Hara Taichi, Nakagawa Eisuke, (Reg)Matsumoto Michiaki
Eutectic mixture
transdermal delivery
O
616Development of Azide-modified Link Module with Click Reactivity
(U. Tokyo) *(Stu)Aono Takumi, (Reg)Inagaki Natsuko, Okawa Masashi, (TUAT) Tera Masayuki, (U. Tokyo) Nakakido Makoto, Tsumoto Kouhei, (Reg)Ito Taichi
Link module
Click chemistry
P
634Sequential control of two cell fates using cell fate-inducing CARs
(NIBIOHN) *(Reg)Kawahara M., Nakajima K., Miura M.
chimeric antigen receptor
cell fate control
signal transduction
O
641Development of adjuvant for subunit vaccines using peptide-based supramolecules
(Kyushu U.) *(Reg)Wakabayashi Rie, Higuchi Ayato, Nabae Yuki, (Reg)Kamiya Noriho, (Reg)Goto Masahiro
Self-assembly
Peptides
Vaccine adjuvant
O
646Membrane cholesterol-binding recombinant proteins for modulating cellular function
(Science Tokyo) *(Reg)Nishida Kei, (Reg)Mie Masayasu, Kobatake Eiry
Cholesterol
Plasma membrane
Endoplasmic reticulum
O
656Establishment of conditions for preparation of chitosan gel particles for nasal sinus wound treatment
(Kagoshima U.) *(Stu,PCEF)Nagase Yuji, (iCUREX) Yoshinaga Takuma, (Kagoshima U.) (Reg)Ohzuno Yoshihiro, (Reg)Kobaru Saki, (Reg)Yoshida Masahiro, (Reg)Takei Takayuki
wound healing
chitosan
hydrogel
P
698Suppression of Drift Caused by Oil Migration in Molecularly Imprinted Carbon Paste Sensors
(Shibaura Inst. Tech.) *(Stu)Otsuka Riku, (Stu)Hirata Aoi, Toyama Shigeru, (Reg)Yoshimi Yasuo
Molecular Imprinting Polymers
Therapeutic drug monitoring
Vancomycin
P
704Development of epidermal dendritic cell-binding peptides for the treatment of novel allergies
(Kyushu U.) *(Stu)Yokoyama Mina, (Reg)Kawaguchi Yoshiro, (Reg)Wakabayashi Rie, (Reg)Kamiya Noriho, (Reg)Goto Masahiro
Peptide
Ribosome display
Allergy
P

List of received applications (By topics code)

List of received applications
SCEJ 90th Annual Meeting (Tokyo, 2025)

Organizing Committee of SCEJ 90th Annual Meeting (2025)
Inquiry